Decheng Capital Management III (Cayman), LLC - PHATHOM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Decheng Capital Management III (Cayman), LLC ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,814,500
-27.6%
850,0000.0%2.94%
-22.9%
Q2 2023$12,172,000850,0003.82%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 2,484,274$27,873,55411.71%
Frazier Life Sciences Management, L.P. 8,407,152$94,328,2455.86%
Abingworth LLP 1,435,106$16,101,8895.25%
Opaleye Management Inc. 417,500$4,684,3501.63%
683 Capital Management, LLC 1,350,000$15,147,0001.28%
Newtyn Management, LLC 484,074$5,431,3101.12%
Penn Mutual Asset Management 62,802$704,6380.79%
StepStone Group LP 422,085$4,735,7940.62%
MPM BioImpact LLC 195,942$2,198,4690.57%
Avidity Partners Management LP 1,900,000$21,318,0000.46%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders